Summary
We describe a family from Japan displaying the mutant insulin syndrome with hyperinsulinaemia and an increased insulin: C-peptide molar ratio. Serum insulin isolated from several family members showed reduced in vitro biological activity, and analysis by high performance liquid chromatography revealed a peak co-eluting with human insulin and a second species of increased hydrophobicity co-migrating with the previously reported Insulin Wakayama. The insulin genes from the propositus were cloned and sequenced, revealing one normal allele; the second allele, encoding a leucine for valine amino acid substitution at position 3 of the insulin A chain, was similar to that previously described for Insulin Wakayama. Synthesized [LeuA3] insulin showed 0.14% of receptor binding activity on rat adipocytes and a 10-fold prolonged half-life in a somatostatin-infused dog compared with human insulin. The finding of the same mutant gene in two unrelated Japanese families suggests that Insulin Wakayama may be discovered in additional Japanese families with hyperinsulinaemia and/or diabetes.
Article PDF
Similar content being viewed by others
References
Kwok SCM, Chan SJ, Rubenstein AH, Poucher R, Steiner DF (1981) Loss of a endonuclease cleavage site in the gene of a structurally abnormal human insulin. Biochem Biophys Res Commun 98: 844–849
Haneda M, Polonsky KS, Bergenstal RM, Jaspan JB, Shoelson SE, Blix PM, Wishner WB, Freidenberg G, Tager HS, Steiner DF, Rubenstein AH (1984) Familial hyperinsulinemia due to a structurally abnormal insulin: Definition of an emerging clinical syndrome. N Engl J Med 310: 1288–1294
Nanjo K, Sanke T, Miyano M, Okai K, Sowa R, Kondo M, Nishimura S, Iwo K, Miyamura K, Given BD, Chan SJ, Tager HS, Steiner DF, Rubenstein AH (1986) Diabetes due to secretion of a structurally abnormal insulin (Insulin Wakayama): Clinical and functional characteristics of [LeuA3] insulin. J Clin Invest 77: 514–519
Goldman J, Baldwin D, Pugh W, Rubenstein AH (1978) Equilibrium binding assay and kinetic characterization of insulin antibodies. Diabetes 27: 653–660
Flier JS, Kahn CR, Roth J, Bar RS (1975) Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190: 63–65
Lernmark A, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Gambhir KK, Archer JA, Bradley CJ (1978) Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701–708
Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH (1986) Site-specific radioimmunoassay in the analysis of circulating proinsulin in hyperinsulnemic states. Metabolism 35: 1137–1146
Shoelson S, Haneda M, Blix P, Nanjo K, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H (1983) Three mutant insulins in man. Nature 302: 540–543
Seed B (1983) Purification of genomic sequences from bacteriophage libraries by recombination and selection in vivo. Nucleic Acids Res 11: 2427–2445
Bell GI, Karam JH, Rutter WJ (1981) A polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Scie USA 78: 5759–5763
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 75: 5463–5467
Haneda M, Chan SJ, Kwok SCM, Rubenstein AH, Steiner DF (1983) Studies on mutant human insulin genes: Identification and sequence analysis of a gene encoding SerB24 insulin. Proc Natl Acad Sci USA 80: 6366–6370
Inouye K, Watanabe K, Tochino Y, Kobayashi M, Shigeta Y (1981) Semisynthesis and properties of some insulin analogs. Biopolymers 20: 1845–1858
Rodbell M (1964) Metabolism of isolated fat cells. The effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375–380
Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS (1984) Human insulin B 24 (Phe→Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. J Clin Invest 73: 1351–1358
Robbins DC, Tager HS, Rubenstein AH (1984) Biological and clinical importance of proinsulin. N Engl J Med 310: 1165–1175
Conn JW, Fajans SS (1961) The prediabetic state: a concept of dynamic resistance to a genetic diabetogenic influence. Am J Med 31: 839–850
Tager H, Given B, Baldwin D, Mako M, Markese J, Rubenstein A, Olefsky J, Kobayashi M, Kilterman O, Poucher R (1979) A structurally abnormal insulin causing human diabetes. Nature 282: 122–125
Given BD, Mako ME, Tager HS, Baldwin D, Markese J, Rubenstein AH, Olefsky J, Kobayashi M, Kolterman O, Poucher R (1980) Diabetes due to secretion of an abnormal insulin. N Engl J Med 302: 129–135
Seino S, Funakoshi A, Fu ZZ, Vinik A (1985) Identification of insulin variants in patients with hyperinsulinemia by reversed-phase high-performance liquid chromatography. Diabetes 34: 1–7
Iwamoto Y, Sakura H, Ishii Y, Okayama K, Yokota O, Kumakura S, Hsieh SD, Sakamoto Y, Matsuda A, Kuzuya T (1985) A new case of familial hyperinsulinemia with diabetes probably due to a structurally abnormal insulin. Diab Ewa Clin Pract Suppl 1: 264
Polonsky K, Jaspan J, Emmanouel D, Holmes K, Moossa AR (1983) Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol 102: 420–427
Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R (1974) A model of the kinetics of insulin in man. J Clin Invest 53: 1481–1492
Castro A, Scott JP, Grettie DP, Macfarlane D, Bailey RE (1970) Plasma insulin and glucose responses of healthy subjects to varying glucose loads during three-hour oral glucose tolerance tests. Diabetes 19: 842–851
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nanjo, K., Miyano, M., Kondo, M. et al. Insulin Wakayama: familial mutant insulin syndrome in Japan. Diabetologia 30, 87–92 (1987). https://doi.org/10.1007/BF00274577
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274577